Alan Paciorek
Overview
Explore the profile of Alan Paciorek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paciorek A, Mulvey C, McKinley M, Zhang L, Cheng I, Moon F, et al.
J Natl Compr Canc Netw
. 2025 Feb;
23(2):27-32.
PMID: 39938473
Background: It is unclear whether patients of all races and ethnicities with gastroenteropancreatic (GEP) neuroendocrine neoplasm (NEN) have equivalent incidence and cancer-specific survival. Patients And Methods: Using the California Cancer...
2.
Masharani U, Lindsay S, Moon F, Paciorek A, Bergsland E
Oncologist
. 2024 Oct;
PMID: 39475415
Background: Multimodal interventions in neuroendocrine tumors appear to have a beneficial impact on survival. Metastatic insulinoma is associated with hypoglycemia and, historically, a shortened life expectancy. Methods: The authors retrospectively...
3.
Nhungo C, Sensa V, Mushi F, Alexandre A, Njiku K, Mwanga A, et al.
BMC Surg
. 2024 Oct;
24(1):315.
PMID: 39415157
Background: Advanced prostate cancer leads to many symptoms, notably bone pain and lower urinary tract symptoms (LUTs); however, the degree and duration of pain relief, changes in LUTs severity and...
4.
Ng D, Vuhahula E, Kimambo A, Ndayisaba M, Philipo G, Mushi B, et al.
Lancet Oncol
. 2024 Oct;
25(11):1440-1452.
PMID: 39369731
Background: Use of fine-needle aspiration biopsy (FNAB) specimens on Xpert Breast Cancer STRAT4 Assay (STRAT4; Cepheid, Sunnyvale, CA, USA), a CE-marked in-vitro diagnostic medical device, could potentially increase access to...
5.
Tolani M, Agbo C, Paciorek A, Umar S, Ojewola R, Mohammed F, et al.
BMC Health Serv Res
. 2024 Aug;
24(1):918.
PMID: 39135037
Background: Prostate cancer mortality rates are high in Nigeria. While prostate cancer is highly curable with early detection and effective multidisciplinary management, the quality of care is suboptimal in this...
6.
Yogo A, Paciorek A, Kasai Y, Moon F, Hirose K, Corvera C, et al.
Ann Surg Oncol
. 2024 May;
31(9):5507-5514.
PMID: 38797790
Background: Ileal neuroendocrine tumors (i-NETs) are characterized by their multifocality and bulky mesenteric mass. Having shown that minimally invasive surgery (MIS) utilizing a hand-access port device has favorable short-term outcomes...
7.
Yadav S, Lawhn-Heath C, Paciorek A, Lindsay S, Mirro R, Bergsland E, et al.
J Nucl Med
. 2024 Mar;
65(3):409-415.
PMID: 38428966
Posttreatment imaging of γ-emissions after peptide receptor radionuclide therapy (PRRT) can be used to perform quantitative dosimetry as well as assessment response using qualitative measures. We aimed to assess the...
8.
Mulvey C, Paciorek A, Moon F, Steiding P, Shih B, Gubens M, et al.
Endocr Relat Cancer
. 2023 Oct;
31(1).
PMID: 37882324
Lung neuroendocrine tumors (NETs) have few known predictors of survival. We investigated associations of sociodemographic, clinicopathologic, and treatment factors with overall survival (OS) and lung cancer-specific survival (LCSS) for incident...
9.
Liu V, Zuniga K, Paciorek A, Zhang L, Chan J, Carroll P, et al.
Support Care Cancer
. 2023 Jul;
31(8):453.
PMID: 37428241
Purpose: Exercise and healthy diet are key components of cancer survivorship. We sought to explore perceived barriers to engaging in healthy diet and exercise, and whether these barriers change throughout...
10.
Le B, McGarrah P, Paciorek A, Mohamed A, Apolo A, Chan D, et al.
Clin Genitourin Cancer
. 2023 Apr;
21(3):403-414.e5.
PMID: 37031047
Background: Primary urinary neuroendocrine neoplasms (U-NENs) are extremely rare thus optimal treatment is unknown. Grading and treatment are typically extrapolated from other primary sites. Since 2010, the clinical landscape for...